IMR OpenIR

浏览/检索结果: 共4条,第1-4条 帮助

已选(0)清除 条数/页:   排序方式:
Synthesis, Anticancer and Antibacterial Activities of Novel 2-Amino-4-phenylthiazole Derivatives Containing Amide Moiety 期刊论文
CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2017, 卷号: 37, 期号: 9, 页码: 2377-2384
作者:  Zhang Zhihua;  Chen Yu;  Chai Baoshan;  Yang Xiaoman;  Cai Xiaoyu;  Cui Bo;  You Song
收藏  |  浏览/下载:146/0  |  提交时间:2021/02/02
BIOLOGICAL EVALUATION  KINASE INHIBITORS  SORAFENIB ANALOGS  ANTITUMOR AGENTS  RATIONAL DESIGN  2-AMINOTHIAZOLES  BRAF  MELANOMA  THIOUREA  GROWTH  thiazole derivative  amide  synthesis  anticancer  antibacterial  
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi;  Zheng Mingyue;  Zhao Dongmei;  Cheng Maosheng;  Geng Meiyu;  Shen Jingkang;  Ai Jing;  Xiong Bing
收藏  |  浏览/下载:160/0  |  提交时间:2021/02/02
RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery  
Discovery of a new series of imidazo1,2-apyridine compounds as selective c-Met inhibitors 期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 5, 页码: 698-707
作者:  Liu Tongchao;  Peng Xia;  Ma Yuchi;  Ji Yinchun;  Chen Danqi;  Zheng Mingyue;  Zhao Dongmei;  Cheng Maosheng;  Geng Meiyu;  Shen Jingkang;  Ai Jing;  Xiong Bing
收藏  |  浏览/下载:134/0  |  提交时间:2021/02/02
RECEPTOR TYROSINE KINASE  INVASIVE GROWTH  SCATTER FACTOR  CANCER  DOCKING  c-Met inhibitors  hepatocyte growth factor receptor  imidazo1,2-apyridine  anticancer agents  drug discovery  
Design, Synthesis and Anticancer Activity of Novel 6-(Aminophenyl)-2,4-bismorpholino-1,3,5-triazine Derivatives Bearing Arylmethylene Hydrazine Moiety 期刊论文
CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2014, 卷号: 30, 期号: 2, 页码: 257-265
作者:  Huang Qiang;  Fu Qiangqiang;  Liu Yajing;  Bai Jinying;  Wang Qianying;  Liao Huimin;  Gong Ping
收藏  |  浏览/下载:126/0  |  提交时间:2021/02/02
POTENTIAL ANTITUMOR AGENTS  BIOLOGICAL EVALUATION  INHIBITOR  MTOR  Bis(morpholino-1,3,5-triazine)  Design  Anticancer activity